1. Home
  2. RAPT vs NMT Comparison

RAPT vs NMT Comparison

Compare RAPT & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • NMT
  • Stock Information
  • Founded
  • RAPT 2015
  • NMT 1993
  • Country
  • RAPT United States
  • NMT United States
  • Employees
  • RAPT N/A
  • NMT N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • NMT Finance/Investors Services
  • Sector
  • RAPT Health Care
  • NMT Finance
  • Exchange
  • RAPT Nasdaq
  • NMT Nasdaq
  • Market Cap
  • RAPT 117.5M
  • NMT 110.6M
  • IPO Year
  • RAPT 2019
  • NMT N/A
  • Fundamental
  • Price
  • RAPT $0.92
  • NMT $12.05
  • Analyst Decision
  • RAPT Buy
  • NMT
  • Analyst Count
  • RAPT 5
  • NMT 0
  • Target Price
  • RAPT $5.25
  • NMT N/A
  • AVG Volume (30 Days)
  • RAPT 1.1M
  • NMT 19.1K
  • Earning Date
  • RAPT 05-08-2025
  • NMT 01-01-0001
  • Dividend Yield
  • RAPT N/A
  • NMT 3.21%
  • EPS Growth
  • RAPT N/A
  • NMT N/A
  • EPS
  • RAPT N/A
  • NMT N/A
  • Revenue
  • RAPT N/A
  • NMT N/A
  • Revenue This Year
  • RAPT N/A
  • NMT N/A
  • Revenue Next Year
  • RAPT N/A
  • NMT N/A
  • P/E Ratio
  • RAPT N/A
  • NMT N/A
  • Revenue Growth
  • RAPT N/A
  • NMT N/A
  • 52 Week Low
  • RAPT $0.71
  • NMT $9.05
  • 52 Week High
  • RAPT $4.60
  • NMT $10.93
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 49.00
  • NMT 63.31
  • Support Level
  • RAPT $0.86
  • NMT $11.91
  • Resistance Level
  • RAPT $1.27
  • NMT $12.33
  • Average True Range (ATR)
  • RAPT 0.13
  • NMT 0.20
  • MACD
  • RAPT 0.01
  • NMT 0.02
  • Stochastic Oscillator
  • RAPT 34.50
  • NMT 69.01

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About NMT Nuveen Massachusetts Quality Municipal Income Fund

Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.

Share on Social Networks: